Education
About Us
Working with TipRanks
Follow Us
Autonomix Medical, Inc. (AMIX)
NASDAQ:AMIX
AMIX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.14 - $21.49
Previous CloseN/A
Volume72.00K
Average Volume (3M)2.52M
Market Cap
$6.62M
Enterprise Value$9.57M
Total Cash (Recent Filing)$11.82M
Total Debt (Recent Filing)$1.13M
Price to Earnings (P/E)―
Beta-0.02
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-12.53
Shares Outstanding5,049,887
10 Day Avg. Volume474,271
30 Day Avg. Volume2,515,901
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.45
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-107.49
Enterprise Value/Ebitda-0.72
Forecast
1Y Price Target
$5.00Price Target Upside303.23% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Bulls Say, Bears Say
Bulls Say
Clinical Trial SuccessAMIX announced positive preliminary results from its proof-of-concept trial, showing significant and sustained pain reduction.
Market ExpansionThe follow-on study has the potential to expand the addressable market beyond pancreatic cancer pain, focusing on interventional cancer pain management applications in liver, gall bladder, and stomach.
Technology InnovationAMIX's breakthrough platform technology could transform the field of electrophysiology by detecting neural signals that indicate pain or disease and destroying those nerves at the source.
Bears Say
Pre-Revenue StatusAMIX is pre-revenue, but its novel technology and significant initial market opportunity in pancreatic cancer pain management justify the price target.
Autonomix Medical, Inc. News
AMIX FAQ
What was Autonomix Medical, Inc.’s price range in the past 12 months?
Autonomix Medical, Inc. lowest stock price was $1.14 and its highest was $21.49 in the past 12 months.
What is Autonomix Medical, Inc.’s market cap?
Autonomix Medical, Inc.’s market cap is $6.62M.
When is Autonomix Medical, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Autonomix Medical, Inc.’s earnings last quarter?
Currently, no data Available
Is Autonomix Medical, Inc. overvalued?
According to Wall Street analysts Autonomix Medical, Inc.’s price is currently Undervalued.
Does Autonomix Medical, Inc. pay dividends?
Autonomix Medical, Inc. does not currently pay dividends.
What is Autonomix Medical, Inc.’s EPS estimate?
Autonomix Medical, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Autonomix Medical, Inc. have?
Autonomix Medical, Inc. has 5,049,887 shares outstanding.
What happened to Autonomix Medical, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Autonomix Medical, Inc.?
Currently, no hedge funds are holding shares in AMIX
Company Description
Autonomix Medical, Inc.
Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.
Autonomix Medical, Inc. (AMIX) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
AMIX Stock 12 Month Forecast
Average Price Target
$5.00
▲(303.23% Upside)
Technical Analysis
Nuwellis
―
Sintx Technologies
―
ReShape Lifesciences
―
Heart Test Laboratories, Inc.
―
Ownership Overview
―
Insiders
0.20% Mutual Funds
<0.01% Other Institutional Investors
99.79% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---